Krka Logo

Krka

An international generic pharmaceutical company developing human and animal health products.

KRKG | LJSE

Overview

Corporate Details

ISIN(s):
SI0031102120
LEI:
549300H9RLRTRTLRUZ73
Country:
Slovenia
Address:
Šmarješka cesta 006, 8501 Novo mesto

Description

Krka is an international generic pharmaceutical company engaged in the development, production, marketing, and sales of human and animal health products. The company's core business is focused on generic prescription pharmaceuticals, which it markets under its own brands. Its product portfolio is complemented by a range of non-prescription products and a comprehensive line of animal health products. With a history spanning over 70 years, Krka is committed to providing high-quality, effective, and safe products to a global market, aiming to contribute to a better quality of life.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2018-06-07 08:30
Counter proposal to item 2 of the agenda of the 24th Annual General Meeting
English 770 bytes
2018-06-07 08:30
Nasprotni predlog delničarja Društvo MDS
Slovene 299.6 KB
2018-06-07 08:30
Nasprotni predlog sklepa 24. skupščine MDS
Slovene 28.8 KB
2018-06-07 08:30
Nasprotni predlog k točki 2 dnevnega reda 24. skupščine
Slovene 1.1 KB
2018-06-06 08:17
Counter_proposal_to_24th_AGM.pdf
Polish 37.9 KB
2018-06-04 08:30
Change in total number of shares with voting rights
English 1.1 KB
2018-06-04 08:30
Sprememba skupnega števila delnic z glasovalno pravico
Slovene 1.4 KB
2018-05-28 08:30
Proxy statement
English 20.2 KB
2018-05-28 08:30
Registration form
English 24.8 KB
2018-05-28 08:30
Shareholders' rights
English 38.6 KB
2018-05-28 08:30
Explanation of proposed resolutions
English 35.0 KB
2018-05-28 08:30
24th Annual General Meeting Notice
English 96.2 KB
2018-05-28 08:30
Pooblastilo za skupščino
Slovene 26.5 KB
2018-05-28 08:30
Prijava udeležbe na skupščine
Slovene 24.5 KB
2018-05-28 08:30
Pravice delničarjev
Slovene 35.7 KB

Automate Your Workflow. Get a real-time feed of all Krka filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Krka

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Krka via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.